Literature DB >> 10826579

An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors.

I P Jensen1, P Thorsen, B Jeune, B R Møller, B F Vestergaard.   

Abstract

OBJECTIVES: To estimate the incidence of human parvovirus B19 among pregnant women before and during an epidemic, to elucidate possible sociodemographic and medical risk factors during pregnancy and to estimate the association between parvovirus B19 infection and negative pregnancy outcome.
DESIGN: Prospective study among pregnant women followed from their first antenatal visit before 24 full weeks of gestation until delivery.
SETTING: Department of Obstetrics and Gynaecology, Odense University Hospital, Denmark, November 1992 to February 1994.
METHODS: 3,596 pregnant women were invited to participate. The women were examined at first antenatal visit in the period from November 1992 to February 1994 and at delivery. The last delivery was in August 1994 and samples were thus collected before and during a large parvovirus B19 epidemic in Denmark January to September 1994. A blood sample for parvovirus B19 serology was taken at enrollment and from the umbilical cord at delivery. Three questionnaires were completed during 2nd and 3rd trimesters and a registration form at delivery. In total, 3,174 (87.6%) were enrolled and 79.5% completed the study.
RESULTS: The prevalence of B19 IgG seropositivity at the first antenatal visit before 24 full weeks of gestation was 66% . The cumulative prevalence proportion of acute parvovirus B19 infection during pregnancy among IgG negative women was found to be 10.3% (IgM seropositivity and/or IgG seroconversion). The IgG seroconversion incidence increased significantly from 1.0% to 13.5% among 932 seronegative pregnant women before and during the epidemic, respectively (P < 0.001). Independent risk factors related to increased risk of B19 infection during pregnancy, adjusted for other sociodemographic and medical factors, were: children at home (adjusted OR 2.1, 95% CI 1.3-3.2); serious medical disease (adjusted OR 3.0, 95% CI 1.0-8.5); and a stressful job (adjusted OR 1.8, 95% CI 1.0-3.3). Parvovirus B 19 IgM seropositivity was associated with events of late spontaneous abortions and stillbirths (crude OR 9.9; 95% CI 3.3-29.4).
CONCLUSION: Before and during an epidemic of acute B19 infection incidences were measured among pregnant women to be 1.0% and 13.5%, respectively. Three factors, significantly increasing the risk of acute B19, were identified as: having children at home; suffering from serious medical diseases; and having a stressful job. IgM positivity for parvovirus B19 was associated with negative outcome of pregnancy.

Entities:  

Mesh:

Year:  2000        PMID: 10826579     DOI: 10.1111/j.1471-0528.2000.tb13306.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  13 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Viral ssRNA induces first trimester trophoblast apoptosis through an inflammatory mechanism.

Authors:  Paulomi B Aldo; Melissa J Mulla; Roberto Romero; Gil Mor; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2010-02-17       Impact factor: 3.886

3.  Placental cellular immune response in women infected with human parvovirus B19 during pregnancy.

Authors:  J A Jordan; D Huff; J A DeLoia
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.

Authors:  M Enders; A Weidner; G Enders
Journal:  Epidemiol Infect       Date:  2006-10-26       Impact factor: 2.451

5.  Viral single stranded RNA induces a trophoblast pro-inflammatory and antiviral response in a TLR8-dependent and -independent manner.

Authors:  Julie A Potter; Manish Garg; Sylvie Girard; Vikki M Abrahams
Journal:  Biol Reprod       Date:  2014-11-26       Impact factor: 4.285

6.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 7.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

8.  Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Authors:  J Dembinski; A M Eis-Hübinger; J Maar; R Schild; P Bartmann
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 9.  Exposure to fifth disease in pregnancy.

Authors:  Arthur Staroselsky; Chagit Klieger-Grossmann; Facundo Garcia-Bournissen; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

10.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.